: WSJ: Moderna may charge up to $130 per dose of its COVID shot


Shares of Moderna Inc. MRNA, +1.97% were up 2.5% in trading on Monday afternoon after the Wall Street Journal reported that the company is considering pricing its COVID-19 vaccine at $110 to $130 per dose. That’s the same price range that Pfizer Inc. PFE, -5.04% and BioNTech BNTX, -0.64%  suggested for their COVID vaccine once the COVID vaccines move into a commercial market. They are currently purchased and distributed by the U.S. government. Moderna’s stock is down 13.4% over the past year, while the broader S&P 500 SPX, -0.02% has declined 17.0%.

This article was originally published by Marketwatch.com. Read the original article here.

Previous articleThe Tell: Morgan Stanley’s Mike Wilson warns U.S. stocks could slump another 22% if recession arrives in 2023
Next articleTesla shares extend end-of-week rally with 6% surge early Monday


Please enter your comment!
Please enter your name here